CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Pharma Logistics

Pharma Logistics is a full service reverse distributor of overstock, expired and in-dated pharmaceutical products. We provide a complete returns solution, 24/7 access to our online client portal and industry leading reporting tools that can present better alternatives to existing purchasing decisions.

Nipro Diabetes Systems

Stago

Clinical Research IO

Our first-of-its-kind software system lets clinical research investigators create e-source templates and use a mobile tablet to capture source data. Research sites can save time, improve accuracy and reduce protocol deviations through our autofill and data validation techniques. Our system also has patient scheduling, recruiting and financial management for a holistic, all-in-one enterprise solution.

Ignite Mental Health

Join us in the fight to end the mental health crisis plaguing our campuses and transform the future of mental health.